
Monday, June 21, 2010 9:21:08 AM
The University of Utah Hospital and INTEGRIS Baptist Medical Center in Oklahoma City have successfully implanted additional Levacor(TM) Ventricular Assist Devices (VAD) in the Bridge-to-Transplant (BTT) clinical study. These are the sixth and seventh implants, respectively, with the Levacor VAD since the inception of the BTT clinical study.
FEATURED Animoca Brands leads Hivello funding round ahead of Token Listing • Feb 10, 2025 10:20 AM
51 Labs Expands Sports Nutrition Line with Five New Innovative Products, Company in final phase of name and ticker symbol change • CAFI • Feb 10, 2025 9:00 AM
UAV Corp. Expanding in the Global UAV Market, Projected to Exceed $58 Billion by 2027, with Increasing Government and Commercial Sector Adoption • UMAV • Feb 6, 2025 8:30 AM
VAYK Project $700K 2024 Revenue with $150K Net Profit • VAYK • Feb 5, 2025 12:43 PM
UAV Corp (UMAV) Kicks Off Landmark "SKY" Hangar Project with Land Clearing at Costin Airport Setting Stage for Q1 2025 Groundbreaking • UMAV • Feb 5, 2025 8:30 AM
HealthLynked Corp. Releases Annual Shareholder Letter Highlighting Recent Product Development and Strategic Vision for the Future • HLYK • Feb 4, 2025 8:00 AM